State Street’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,680,802
| Closed | -$89.8M | – | 4264 |
|
|
2026
Q1 | $89.8M | Buy |
2,680,802
+31,176
| +1% | +$1.22M | ﹤0.01% | 1431 |
|
|
2025
Q4 | $123M | Buy |
2,649,626
+476,590
| +22% | +$26.1M | ﹤0.01% | 1241 |
|
|
2025
Q3 | $147M | Buy |
2,173,036
+768,053
| +55% | +$56.9M | 0.01% | 1128 |
|
|
2025
Q2 | $118M | Buy |
1,404,983
+235,784
| +20% | +$17.6M | ﹤0.01% | 1215 |
|
|
2025
Q1 | $83.5M | Sell |
1,169,199
-177,820
| -13% | -$8.66M | ﹤0.01% | 1360 |
|
|
2024
Q4 | $60.5M | Buy |
1,347,019
+204,850
| +18% | +$10.6M | ﹤0.01% | 1631 |
|
|
2024
Q3 | $57.7M | Buy |
1,142,169
+142,033
| +14% | +$6.8M | ﹤0.01% | 1629 |
|
|
2024
Q2 | $40.8M | Buy |
1,000,136
+29,566
| +3% | +$1.25M | ﹤0.01% | 1775 |
|
|
2024
Q1 | $41.5M | Buy |
970,570
+469,168
| +94% | +$21.2M | ﹤0.01% | 1816 |
|
|
2023
Q4 | $20.2M | Buy |
501,402
+485,954
| +3,146% | +$13.8M | ﹤0.01% | 2206 |
|
|
2023
Q3 | $456K | Hold |
15,448
| – | – | ﹤0.01% | 3688 |
|
|
2023
Q2 | $66.3K | Hold |
15,448
| – | – | ﹤0.01% | 4337 |
|
|
2023
Q1 | $33.1K | Hold |
15,448
| – | – | ﹤0.01% | 4607 |
|
|
2022
Q4 | $30.6K | Hold |
15,448
| – | – | ﹤0.01% | 4665 |
|
|
2022
Q3 | $26K | Sell |
15,448
-1
| -0% | -$2 | ﹤0.01% | 4788 |
|
|
2022
Q2 | $43K | Hold |
15,449
| – | – | ﹤0.01% | 4749 |
|
|
2022
Q1 | $52K | Buy |
15,449
+776
| +5% | +$4.02K | ﹤0.01% | 4784 |
|
|
2021
Q4 | $90K | Hold |
14,673
| – | – | ﹤0.01% | 4600 |
|
|
2021
Q3 | $203K | Hold |
14,673
| – | – | ﹤0.01% | 4356 |
|
|
2021
Q2 | $251K | Sell |
14,673
-41,753
| -74% | -$705K | ﹤0.01% | 4129 |
|
|
2021
Q1 | $1.07M | Buy |
56,426
+8,334
| +17% | +$269K | ﹤0.01% | 3612 |
|
|
2020
Q4 | $1.39M | Buy |
48,092
+22,403
| +87% | +$647K | ﹤0.01% | 3490 |
|
|
2020
Q3 | $967K | Buy |
25,689
+5,765
| +29% | +$168K | ﹤0.01% | 3448 |
|
|
2020
Q2 | $663K | Buy |
+19,924
| New | +$863K | ﹤0.01% | 3502 |
|
State Street's SLNO Position: Q2 2026 in Review
State Street sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 2,680,802 shares — an estimated $89.8M sold.
State Street first reported a position in SLNO in Q2 2020 and held it in 24 quarters. The position peaked at $147M in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- State Street reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- State Street sold 2,680,802 Soleno Therapeutics shares in Q2 2026, an estimated $89.8M.
- State Street first reported a position in Soleno Therapeutics in Q2 2020 and held it in 24 quarters.
- State Street's Soleno Therapeutics position peaked at $147M in Q3 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.